1. Home
  2. NVCT vs PKE Comparison

NVCT vs PKE Comparison

Compare NVCT & PKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • PKE
  • Stock Information
  • Founded
  • NVCT 2020
  • PKE 1954
  • Country
  • NVCT United States
  • PKE United States
  • Employees
  • NVCT N/A
  • PKE N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • PKE Military/Government/Technical
  • Sector
  • NVCT Health Care
  • PKE Industrials
  • Exchange
  • NVCT Nasdaq
  • PKE Nasdaq
  • Market Cap
  • NVCT 249.1M
  • PKE 260.4M
  • IPO Year
  • NVCT 2022
  • PKE N/A
  • Fundamental
  • Price
  • NVCT $8.99
  • PKE $13.28
  • Analyst Decision
  • NVCT Strong Buy
  • PKE
  • Analyst Count
  • NVCT 3
  • PKE 0
  • Target Price
  • NVCT $17.00
  • PKE N/A
  • AVG Volume (30 Days)
  • NVCT 157.3K
  • PKE 45.6K
  • Earning Date
  • NVCT 05-06-2025
  • PKE 05-29-2025
  • Dividend Yield
  • NVCT N/A
  • PKE 3.75%
  • EPS Growth
  • NVCT N/A
  • PKE N/A
  • EPS
  • NVCT N/A
  • PKE 0.36
  • Revenue
  • NVCT N/A
  • PKE $61,420,000.00
  • Revenue This Year
  • NVCT N/A
  • PKE N/A
  • Revenue Next Year
  • NVCT N/A
  • PKE N/A
  • P/E Ratio
  • NVCT N/A
  • PKE $37.30
  • Revenue Growth
  • NVCT N/A
  • PKE 15.45
  • 52 Week Low
  • NVCT $4.44
  • PKE $11.96
  • 52 Week High
  • NVCT $11.80
  • PKE $15.57
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 47.46
  • PKE 51.24
  • Support Level
  • NVCT $8.01
  • PKE $12.91
  • Resistance Level
  • NVCT $9.62
  • PKE $13.52
  • Average True Range (ATR)
  • NVCT 1.04
  • PKE 0.32
  • MACD
  • NVCT -0.16
  • PKE 0.04
  • Stochastic Oscillator
  • NVCT 27.96
  • PKE 57.81

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About PKE Park Aerospace Corp.

Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.

Share on Social Networks: